Our Goals

BOLTII DIAGNOSTICS, INC. is an emerging biotech company focused on using our groundbreaking DirectLAMP technology to develop colorimetric LAMP-based molecular diagnostics for infectious diseases, with a particular emphasis on using urine as the input sample. Our strategy is based on several considerations. First, there is an unmet need for simple, cost-effective, and rapid point-of-care molecular diagnostics for urinary tract infections. Second, urine is a relatively homogeneous sample type that is highly compatible with our DirectLAMP technology. Third, urine samples are readily accessible, and their collection is simple and noninvasive, making it the most suitable specimen for point-of-care and at-home molecular diagnostics.

DirectLAMP Tests for Infectious Diseases

TM

Bacterial urinary tract infections

Urinary tract infections (UTIs) are caused by bacteria in 85% of cases, making them among the most prevalent bacterial infections seen in clinics. Traditionally, UTI diagnosis has relied on urine cultures, which can take 24-48 hours to produce results. However, with DirectLAMP diagnostics, patients and their doctors can identify the infecting bacterial species and strain within just 1-2 hours. Rapid identification of the bacterium responsible for UTI can have a significant impact on timely antibiotic treatment, potentially avoiding serious complications such as septic shock.